274 related articles for article (PubMed ID: 27548722)
1. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
[TBL] [Abstract][Full Text] [Related]
2. The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells.
Jaaks P; Meier G; Alijaj N; Brack E; Bode P; Koscielniak E; Wachtel M; Schäfer BW; Bernasconi M
Oncotarget; 2016 Nov; 7(47):76743-76755. PubMed ID: 27572312
[TBL] [Abstract][Full Text] [Related]
3. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
[TBL] [Abstract][Full Text] [Related]
6. Type XIX collagen: A new partner in the interactions between tumor cells and their microenvironment.
Oudart JB; Monboisse JC; Maquart FX; Brassart B; Brassart-Pasco S; Ramont L
Matrix Biol; 2017 Jan; 57-58():169-177. PubMed ID: 27491275
[TBL] [Abstract][Full Text] [Related]
7. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
8. The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation.
Miekus K; Lukasiewicz E; Jarocha D; Sekula M; Drabik G; Majka M
Cell Death Dis; 2013 Jan; 4(1):e459. PubMed ID: 23328666
[TBL] [Abstract][Full Text] [Related]
9. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
10. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin.
López de Cicco R; Bassi DE; Zucker S; Seidah NG; Klein-Szanto AJ
Cancer Res; 2005 May; 65(10):4162-71. PubMed ID: 15899807
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
[TBL] [Abstract][Full Text] [Related]
12. Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications.
Wysoczynski M; Shin DM; Kucia M; Ratajczak MZ
Int J Cancer; 2010 Jan; 126(2):371-81. PubMed ID: 19588509
[TBL] [Abstract][Full Text] [Related]
13. Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo.
Tarnowski M; Tkacz M; Zgutka K; Bujak J; Kopytko P; Pawlik A
BMC Cancer; 2017 Aug; 17(1):532. PubMed ID: 28793874
[TBL] [Abstract][Full Text] [Related]
14. Stable silencing of dll4 gene suppresses the growth and metastasis of esophagus cancer cells by attenuating Akt phosphorylation.
Guo X; Duan Y; Ye X; Hu L; Xu T; Tong L; Yu M
Oncol Rep; 2018 Jul; 40(1):495-503. PubMed ID: 29749499
[TBL] [Abstract][Full Text] [Related]
15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
17. Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.
Cao L; Yu Y; Darko I; Currier D; Mayeenuddin LH; Wan X; Khanna C; Helman LJ
Cancer Res; 2008 Oct; 68(19):8039-48. PubMed ID: 18829562
[TBL] [Abstract][Full Text] [Related]
18. Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition.
Megiorni F; McDowell HP; Camero S; Mannarino O; Ceccarelli S; Paiano M; Losty PD; Pizer B; Shukla R; Pizzuti A; Clerico A; Dominici C
J Exp Clin Cancer Res; 2015 Oct; 34():112. PubMed ID: 26445453
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
[TBL] [Abstract][Full Text] [Related]
20. Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.
Hajdin K; D'Alessandro V; Niggli FK; Schäfer BW; Bernasconi M
PLoS One; 2010 May; 5(5):e10445. PubMed ID: 20454619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]